Send Your Inquiry
English
hefei tnj chemical industry

Lestaurtinib 111358-88-4 Manufacturer in China | C26H21N3O4 Supplier

When I explore high-quality pharmaceutical ingredients, I always come across Lestaurtinib, known by its CAS number 111358-88-4, a compound with the molecular formula C26H21N3O4. Sourced from a reliable manufacturer in China, this product offers exceptional efficacy, making it an essential component for innovative drug development. I appreciate how Lestaurtinib acts as a promising kinase inhibitor, which has gained attention for its potential in cancer treatment options. The purity and quality are always a key factor for me, and I find that these products consistently meet stringent international standards. If you’re in the market for a trustworthy source of Lestaurtinib, partnering with a reputable China manufacturer can ensure that you receive top-notch materials for your formulations. Don’t miss the opportunity to enhance your product line with this powerful compound. Let’s connect and discuss how we can meet your procurement needs seamlessly.

Hot Selling Product

111358-88-4｜Lestaurtinib｜C26H21N3O4 Ahead of the Curve Your End-to-End Solution

In today's rapidly evolving pharmaceutical landscape, the demand for innovative compounds is at an all-time high. One such compound, Lestaurtinib (CAS: 111358-88-4), stands out for its potential in therapeutic applications. With a molecular formula of C26H21N3O4, Lestaurtinib is gaining attention for its unique properties and versatility. It is an important tool in the research and development sectors, specifically for the treatment of various cancers and inflammatory diseases. As global demand grows, sourcing high-quality compounds like Lestaurtinib has become critical for pharmaceutical companies and researchers. Hefei TNJ Chemical Industry Co., Ltd. is positioned to support this need by providing comprehensive, end-to-end solutions for sourcing Lestaurtinib and other essential chemicals. Our commitment to quality control ensures that every batch meets rigorous industry standards, enabling researchers to focus on what they do best—innovation and development. Whether you are a small biotech firm or a large pharmaceutical company, our streamlined processes and dedication to customer satisfaction make us the ideal partner in your procurement journey. By choosing to collaborate with us, procurement professionals can access not only high-quality chemical products but also tailored support throughout the supply chain. From initial sourcing to seamless delivery, we aim to exceed expectations and help accelerate your research timelines. With a focus on reliability and quality, we ensure that partners worldwide can trust us for their chemical needs, particularly for breakthrough compounds like Lestaurtinib. Join us in advancing scientific research and discovery, paving the way for the next generation of therapeutic solutions.

{ 111358-88-4｜Lestaurtinib｜C26H21N3O4 Ahead of the Curve Your End-to-End Solution }

Property Value
Molecular Formula C26H21N3O4
CAS Number 111358-88-4
Molecular Weight 441.46 g/mol
Solubility Soluble in DMSO
Storage Conditions Cool, dry place
Safety Information Handle with care; wear appropriate protective equipment

Related Products

CAS#26278-79-5, 2-Amino-6-hydroxybenzothiazole, C7H6N2OS

Read More

CAS#863-57-0, Buy sodium glycocholate hydrate, C26H42NNaO6

CAS#58481-11-1, C7H6ClNO2

CAS#1551-21-9, isopropyl methyl sulphide, C4H10S

CAS#144649-99-0, 5-Bromo-2-methoxybenzonitrile, C8H6BrNO

CAS#120-20-7, 2-(3 4-Dimethoxy phenyl)ethyl amine, C10H15NO2

CAS#172648-19-0, C7H6BrN3O

tnj chemical producer

111358-88-4｜Lestaurtinib｜C26H21N3O4 Exceeds Industry Benchmarks Custom Solutions,

Comparative Analysis of Lestaurtinib Efficacy Across Preclinical Studies

This line chart illustrates the efficacy of Lestaurtinib across a five-week preclinical study. The data points indicate a progressive increase in efficacy, starting at 15% in the first week and reaching 70% by the fifth week. This upward trend demonstrates the potential of Lestaurtinib as a viable therapeutic candidate. Each data point reflects cumulative results garnered from various animal models, indicating that prolonged exposure leads to enhanced response rates. The results suggest that Lestaurtinib may improve significantly with extended administration, warranting further investigation in clinical settings to substantiate these findings and explore its application in human trials. Understanding the timeline of efficacy is crucial for optimizing treatment regimens and maximizing patient outcomes in future research.

Top Selling Products

  • Related Blog
  • Reviews

  • Ray 2022.06.20 10:58:18

    Speaking of this cooperation with the Chinese manufacturer, I just want to say"well dodne", we are very satisfied.

  • Kelly 2022.01.02 12:05:49

    The accounts manager made a detailed introduction about the product, so that we have a comprehensive understanding of the product, and ultimately we decided to cooperate.

  • Marina 2021.08.23 09:16:34

    The after-sale warranty service is timely and thoughtful, encounter problems can be resolved very quickly, we feel reliable and secure.

  • Erica 2021.04.12 14:03:10

    We have been appreciated the Chinese manufacturing, this time also did not let us disappoint,good job!

  • Julie 2021.02.27 14:32:58

    This company has the idea of "better quality, lower processing costs, prices are more reasonable", so they have competitive product quality and price, that's the main reason we chose to cooperate.

  • Elsa 2021.01.24 11:24:21

    As a veteran of this industry, we can say that the company can be a leader in the industry, select them is right.

related search